ARK Investment Management Chemomab Therapeutics Ltd ownership

Chemomab Therapeutics Ltd's ticker is CMMB and the CUSIP is 16385C104. A total of 2 filers reported holding Chemomab Therapeutics Ltd in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

ARK Investment Management ownership history of Chemomab Therapeutics Ltd
ValueSharesWeighting
Q1 2022$4
-99.8%
792
-99.7%
0.00%
-100.0%
Q4 2021$1,844
-7.8%
267,292
+48.1%
0.01%
+20.0%
Q3 2021$2,000180,5230.01%